A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT07658183 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07658183
- Sponsor
- Shanghai Best-Link Bioscience, LLC
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-20
- Primary completion
- 2027-10-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.